Lilly Denied Quick Win On Willful Infringement Under Halo
Eli Lilly and Co. was recently denied a quick ruling on whether it willfully infringed a patent covering enlarged-prostate treatments by selling erectile dysfunction drug Cialis, with the Eastern District of...To view the full article, register now.
Already a subscriber? Click here to view full article